issue. Morbidities linked to postpartum anemia include depression, 3, 4 fatigue, 5 and impaired cognition. 6 These patient-centric outcomes can have important negative impacts on maternal-child bonding and the mother's ability to provide newborn care. 7 Because symptoms of maternal anemia are nonspecific, 8 anemia can only be detected by measuring the hemoglobin (Hb) level. If postpartum anemia goes unrecognized, mothers may face a greater degree of physical or emotional hardship than nonanemic mothers. Therefore, to limit the likelihood of anemia-related morbidity, population-level data are needed to inform guideline development for postpartum anemia screening. Predelivery anemia and postpartum hemorrhage (PPH) are presumed to confer the greatest risks to women for postpartum anemia. 8 Women who undergo Cesarean section may be particularly susceptible to postpartum anemia because their risk of PPH is higher than women undergoing vaginal delivery. 9, 10 However, there is a dearth of studies examining the frequency of anemia after Cesarean section and the relations between predelivery anemia and PPH with postpartum anemia. These studies will be important in advancing clinical knowledge and providing key epidemiologic data for guiding discussions about optimizing patient blood management in obstetrics.
The main objectives of this analysis were to describe the incidence of severe postpartum anemia, assess the relationships between severe postpartum anemia with blood loss at delivery and predelivery anemia, and to estimate the frequencies of these characteristics among women with severe postpartum anemia. In our secondary analyses, we calculated rates of postpartum anemia testing after Cesarean section and examined characteristics of women who did not undergo postpartum Hb testing. For these analyses, we employed data from Kaiser Permanente Northern California (KPNC), a prepaid integrated health care delivery system in the United States.
MATERIALS AND METHODS
This study was approved by the KPNC and Stanford University institutional review boards and the Committee for the Protection of Human Subjects of the California Health and Human Services Agency.
Data source and study cohorts
We used the existing research infrastructure of an integrated health care delivery system (KPNC) in California. All KPNC hospitals and clinics use information systems that are linked by a common medical record number. For this study, data were obtained from linked electronic databases within KPNC, cleaned, and processed using methods previously described. [11] [12] [13] A flow diagram depicts the cohorts used for our primary, subgroup, and secondary analyses (Fig. 1 The main independent variables of interest were predelivery anemia and PPH. Predelivery anemia was determined using the antenatal Hb level closest to the day of Cesarean section. During pregnancy, the WHO defines mild, moderate, and severe anemia as a Hb level between 10 and 10.9, 7 and 9.9, and less than 7 g/dL, respectively. 14 As only 11 women in our study cohort had a predelivery Hb level of less than 7 g/dL, we reclassified predelivery anemia as follows: "mild" for Hb values between 10 to 10.9 g/dL and "moderate-severe" for Hb values of less than 10 g/dL. We identified PPH using International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9) diagnosis codes for PPH (see Table S1 ), available as supporting information in the online version of this paper.
For our subgroup (n 5 38,086) who delivered between 2010 and 2013 ( Fig. 1, flow diagram) , instead of the ICD-9 code for PPH, we used EBL data from the EMR to classify grades of blood loss severity at delivery. Descriptions of the methods of EBL measurement or estimation were not available in KPNC databases. Based on literature review, 9, [17] [18] [19] we classified normal blood loss, nonsevere PPH, and severe PPH based on the following EBL criteria: less than 1000, 1000 to 1499, and 1500 mL or more, respectively. Due to uncertainties about the accuracy of very low EBL values, we classified any EBL of less than 100 mL as missing data (n 5 345).
Other covariates in our analyses included patient and clinical characteristics, specified a priori, as potential confounders between the main independent variables and severe postpartum anemia. These were determined according to clinical relevance and prior literature review. 8, 20 Demographic characteristics included age, race or ethnic group, and year of delivery. Medical characteristics included hereditary or acquired coagulation disorders and thrombocytopenia. Obstetric and peripartum characteristics included gestational age at delivery, grand multiparity, number of prior Cesarean deliveries, obesity, labor, maternal hypertensive disease, placenta previa, antepartum hemorrhage, and transfusion. Maternal age, number of prior Cesarean deliveries, gestational age at delivery, and year of delivery were extracted from linked KPNC databases. Data on mothers' self-reported race and ethnicities were obtained from the State of California Birth Certificate Database. We used ICD-9 codes to identify diagnoses and procedures associated with each delivery hospitalization (Table S1 ).
Statistical analysis
We calculated the number of days between predelivery Hb measurement and Cesarean section, discharge Hb measurement and Cesarean section, and the postpartum length of stay. Overall rates of anemia were calculated, and Wilson's method was used to derive 95% confidence intervals (CIs). 21 To evaluate temporal trends, we calculated annual rates of severe postpartum anemia at discharge. We also calculated annual rates of severe postpartum anemia for deliveries that were accompanied with ICD-9 codes for PPH or transfusion. Temporal trends were assessed using the chi-square test for linear trend in proportions.
We performed bivariate analyses to compare the distribution of patient and obstetric characteristics between women with versus without severe postpartum anemia. We used multivariable logistic regression to assess the associations between the predelivery Hb categories and PPH with severe postpartum anemia. We created separate logistic models to account for the influence of patient and obstetric characteristics, and year of delivery. Sequential models were constructed with increasing levels of adjustment for the following sets of covariates: Model 1 Table 3 Cesarean sections with a recorded postpartum Hb level N = 70,939 Data presented in Tables 1 and 2 Fig. 1. Flow chart.
obstetric characteristics (including obesity, grand multiparity, hereditary or acquired coagulation disorders, thrombocytopenia, gestational age, number of prior Cesarean deliveries, hypertensive disorders of pregnancy, labor or induction of labor, placenta previa, and antepartum hemorrhage). Individual hospitals were accounted for as random effects in each model. For each model, we calculated odds ratios (ORs) for severe postpartum anemia at discharge as a function of the key variables of interest. To estimate the proportion of women with severe postpartum anemia that would have been eliminated if one of the main exposures (predelivery anemia or PPH) had been eliminated, we calculated population attributable fractions (based on adjusted odds ratios [aORs] from nonhierarchical multivariable logistic models). Using full models, we also added interaction terms to investigate whether effect modification occurred between transfusion with PPH and predelivery anemia, respectively.
For our subgroup analyses, we examined data from 38,086 Cesarean sections that occurred between 2010 and 2013 (see Fig. 1 , flow diagram). We calculated absolute rates of severe postpartum anemia according to the presence or absence of PPH (based on available EBL data) and predelivery anemia. We also analyzed data from 35, 614 Cesarean sections where EBL data were not missing (see Fig. 1 , flow diagram) to examine the relations between predelivery anemia and PPH (using EBL categories) with severe postpartum anemia.
Finally, in our secondary analyses, we performed multivariable logistic regression to identify characteristics that may explain why 13,086 women who underwent Cesarean section between 2005 and 2013 did not undergo testing for postpartum anemia (see Fig. 1, flow diagram) . All analyses were conducted using computer software (SAS, Version 9.2, SAS Institute, Inc.; and STATA, Version 12, StataCorp.).
RESULTS
Between 2005 and 2013, we identified 84,025 hospitalizations for Cesarean delivery. The median postpartum Fig. S1 , available as supporting information in the online version of this paper).
Characteristics of women with severe postpartum anemia
Maternal and obstetric characteristics of women with and without severe postpartum anemia at discharge are presented in Table 1 . (The proportions of women with severe postpartum anemia for each maternal or obstetric characteristic [row percentages] are presented in Table S2 , available as supporting information in the online version of this paper). On univariate analyses, women with mild or moderate-severe predelivery anemia and those with PPH were more likely to have severe postpartum anemia. Table  2 shows the crude and adjusted logistic regression models between predelivery anemia and PPH with postpartum anemia. For each predictor, the odds of severe postpartum anemia was relatively unchanged after adjustment for birth year and medical and obstetric characteristics; in Model 4, the aOR was 5.4 among women with mild predelivery anemia (95% CI, 4.89-5.91), 30.6 among those with moderate-severe predelivery anemia (95% CI, 27.21-34.6), and 8.45 among those with PPH (95% CI, 7.8-9.16). (Point estimates for all covariates in Model 4 are presented in Table S2 .) The proportion of severe postpartum anemia that could be attributed to PPH was 13.7% (95% CI, 12.6%-14.8%) and predelivery anemia (Hb < 11 g/dL) was 30.6% (95% CI, 28.7%-32.4%).
Interactions according to transfusion were significant; therefore, we performed stratified analyses to account for the presence or absence of transfusion (Table S3 , available as supporting information in the online version of this paper). In the nontransfused cohort, PPH, mild predelivery anemia, and moderate-severe anemia remained independently associated with severe postpartum anemia. In contrast, in the transfused cohort, the aOR was 2.12 (95% CI, 1.37-3.26) among those with mild predelivery anemia, 1.77 (95% CI, 1.11-2.81) among those with moderatesevere predelivery anemia, and 0.64 (95% CI, 0.49-0.84) among those with PPH.
Subgroup analyses
In our subgroup analyses, we examined data from 38,086 women who underwent Cesarean section between 2010 and 2013 (Fig. 1, flow diagram) . Where available, EBL data were extracted from the EMR, and PPH was classified according to EBL severity. We calculated proportions for severe postpartum anemia according to the presence or absence of the following key factors: predelivery anemia with or without PPH with or without transfusion ( Table  3) . Of those with severe postpartum anemia, 12.2% (95% CI, 9.6%-12.0%) of women had PPH but did not incur predelivery anemia nor transfusion, and 10.7% (95% CI, 11.0%-13.6%) of women had a normal EBL, had no predelivery anemia, and did not receive transfusion.
For 35,614 women with a recorded EBL of at least 100 mL (see Fig. 1, flow diagram) , we performed multivariate logistic regression to assess the relationships between predelivery Hb and PPH (using EBL categories) with severe postpartum anemia. The results are presented in Table S4 (available as supporting information in the (Fig. 1) ; dependent variable is severe postpartum anemia (n 5 5,143). †Unadjusted model. ‡Adjusted for year of birth as a fixed effect and individual hospital as a random effect. §Adjusted for year of birth, maternal age, and race/ethnicity as fixed effects and individual hospital as a random effect. ¶Adjusted for year of birth, maternal age, race/ethnicity, grand multiparity, hereditary or acquired coagulation disorders, gestational age at delivery, number of prior Cesarean deliveries, obesity, thrombocytopenia, preeclampsia, labor, placenta previa, antepartum hemorrhage as fixed effects, and individual hospital as a random effect.
online version of this paper). Compared to women with an EBL of less than 1000 mL, women who experienced moderate PPH (EBL 1000-1499 mL) or severe PPH (EBL 1500 mL) had a 3.9-and 13.4-fold increased odds of severe postpartum anemia, respectively.
Secondary analyses
For our secondary analyses, we examined 13,086 women who underwent Cesarean section who did not have a recorded postpartum Hb (see Fig. 1, flow diagram) . Characteristics of women with no recorded postpartum Hb value are presented in Table S5 (available as supporting information in the online version of this paper). Women who delivered at less than 37 weeks' gestational age had the highest odds of not undergoing postpartum Hb testing (aOR, 156.9). Women of unknown ethnicity and those without a predelivery Hb value had a threefold increased odds of not getting tested. In contrast, the odds of not getting tested were lowest for women who underwent one or at least two prior Cesarean sections compared to women who underwent primary Cesarean section. Within our full subgroup (n 5 38,086), we calculated proportions for women with missing Hb values at discharge (Table S6 , available as supporting information in the online version of this paper); those with missing predelivery Hb values who experienced normal blood loss and no transfusion accounted for the highest proportion (56.7%; 95% CI, 55.4%-58.0%).
DISCUSSION
With anemia management and blood loss minimization approaches being central tenets of good patient blood management practice for surgical and medical patients, [22] [23] [24] our findings that predelivery anemia and PPH are strong risk factors for severe postpartum anemia are timely and topical. Because predelivery anemia is a modifiable risk factor, our findings should prompt key stakeholders, including transfusion medicine specialists, obstetricians, and anesthesiologists, to examine ways to better detect and treat anemia before Cesarean section. Until patient blood management guidelines that are applicable to obstetrics are published, we recommend that anemia screening after Cesarean section be considered for patients with predelivery anemia or no recorded predelivery Hb level or those who experience PPH. In our analyses, predelivery anemia and PPH were identified as strong risk factors for severe postpartum anemia after Cesarean section. After accounting for potential maternal and obstetric covariates in our sequential models, the magnitude of these associations remained relatively unchanged. These findings have important clinical relevance for several reasons. First, predelivery anemia and PPH are not infrequent; predelivery anemia affects 25% of pregnant women 1 and the rate of PPH during Cesarean section is approximately 9%. 25 Second, there is underappreciation of the negative health burden associated with postpartum anemia. Postpartum anemia may precipitate or worsen depressive symptoms, cognitive function, Fig. 1 ); this subset developed severe postpartum anemia.
fatigue, reduced work performance, and maternal-infant bonding. [3] [4] [5] [6] [7] [8] Third, few recommendations exist for detecting severe anemia after Cesarean section. The Centers for Disease Control and Prevention recommend targeted screening for anemia between 4 and 6 weeks postpartum. 26 However, the value of this guidance is uncertain as acute or subacute postpartum anemia can develop much earlier (at 24-48 hr postpartum). 8, 20 Therefore, if severe anemia goes unrecognized after Cesarean section, these women may face greater emotional or physical hardship than nonanemic mothers after hospital discharge. Fourth, because predelivery anemia is a modifiable antepartum risk factor, the early identification and treatment of predelivery anemia may reduce the incidence of severe postpartum anemia after Cesarean section. In the nonobstetric surgical setting, similar approaches have been recommended for the management of preoperative anemia by experts in patient blood management. 22, 27 Although predelivery anemia and PPH were important risk factors, a high proportion of women with severe postpartum anemia (10.7%) had a "normal" EBL and no predelivery anemia. Even with quantitative data for blood loss, clinicians are prone to underestimating blood loss as the volume of actual blood loss increases. 28, 29 As a consequence, screening for postpartum anemia during the early postpartum period may be helpful for early diagnosis and initiation of therapy, 8 especially for those with predelivery anemia or who experience PPH. 30 Of note, specific recommendations for detecting and treating women with iron deficiency anemia among pregnant and nonpregnant women have been published by an expert multidisciplinary group, sponsored by the Society for the Advancement of Blood Management. 31 These recommendations may serve as an important foundation for formally establishing patient blood management guidelines in obstetrics. We acknowledge that others have also observed an association between PPH and early postpartum anemia. 20, [32] [33] [34] However, the majority of these studies focused on women who underwent vaginal delivery, and data on the prevalence of severe postpartum anemia after Cesarean delivery are more limited. Horowitz and colleagues 35 reported that the incidence of severe anemia (Hb < 8 g/ dL) after elective Cesarean delivery is 0.5%. However, this small cohort was sourced from a single obstetric center and did not include intrapartum Cesarean sections; thus, study generalizability is limited. In our study, transfusion modified the associations between PPH and predelivery anemia with severe postpartum anemia. Because we relied on ICD-9 codes to identify women who received transfusions, we cannot determine the context, triggers, timing, or appropriateness of transfusion. This has clinical relevance because transfusion is recognized to be an important indicator of maternal morbidity. 36 Less is known about the use of transfusion thera- Based on our analysis, the proportion of women with severe postpartum anemia who did not undergo predelivery Hb testing and who did not experience PPH or transfusion was relatively high (9.9%). Therefore, it is unclear whether these women had unrecognized predelivery anemia and/or underestimated blood loss. Furthermore, 16% of women in our cohort did not undergo postpartum Hb testing. Women undergoing preterm Cesarean delivery had the highest odds of not getting tested (aOR, 261), whereas the odds were lowest for women with at least one prior Cesarean. These findings emphasize the need for formal guidelines or protocols to standardize anemia screening approaches after Cesarean section.
The main strengths of our study are that we obtained postpartum Hb levels for 70,939 Cesarean sections, with recorded clinical data on blood loss available for more than 50% of our cohort. However, our study has several limitations. For our main analysis, we identified PPH using ICD-9 codes; therefore, misclassification is a potential concern. Nondifferential misclassification can typically bias results toward the null. Using EBL data to classify PPH, we still observed a strong associations between PPH and severe postpartum anemia in our follow-up analysis. Nonetheless, we acknowledge that the true exposure effect of blood loss severity on our primary outcome may have been underestimated. We could not account for all potential confounders in our logistic models, such as labor augmentation with oxytocin, type and volume of intravenous (IV) fluids administered before delivery, and body mass index. However, the point estimates for PPH and chronic anemia remained relatively unchanged in our sequential models, thus these associations are unlikely to be markedly affected by residual confounders. We did not assess whether women received medication, such as oral or IV iron, to prevent or treat postpartum anemia. Stabilization of maternal Hb values occurs between 5 and 7 days postpartum. 8 As the median length of postpartum stay was 3 days, postpartum Hb levels may not have completely stabilized by the time of hospital discharge. Due to the observational nature of our study design, we could not examine factors that influence physicians' decision to transfuse or screen for anemia before or after Cesarean section. Although obstetric agencies are focusing attention on initiatives to reduce major maternal morbidity, 41, 42 future studies are needed to determine whether improvements in anemia screening and the use of non-RBCbased therapies can improve patient-centric outcomes, including debilitating maternal quality of life disorders, such as fatigue and depression. Using a contemporary obstetric cohort, our results provide insight into the epidemiology of severe postpartum anemia after Cesarean section. With anemia detection, diagnosis, and treatment recognized as key facets of patient blood management, we encourage transfusion medicine and other health specialists to consider strategies to potentially reduce the incidence of severe postpartum anemia. Until national guidelines are updated, hospitals and providers may need to consider anemia screening after Cesarean section for women with at least one of the following: predelivery anemia, no predelivery Hb level, and PPH.
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